It was early observed in patients with myelodysplastic syndrome that SF3B1 and SRFS2 mutations are associated with a downregulated mirtronic miR-3605-5p and miR-4728-5p [39]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.